Polyclonal antibody of 50 µl targeting SLC22A12/URAT1 for FCM, ICC, IHC.
| Product Specifications | |
| Application | FC, ICC, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | Synthetic peptide derived from human SLC22A12 |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Formulation | 50 µl volume of PBS containing50% glycerol, pH 7.2. No preservative is contained. |
| Citations for Anti-SLC22A12 (URat1) (Human) pAb – 2 Found |
| Tojo, Akihiro; Asaba, Kensuke; Kinugasa, Satoshi; Ikeda, Yoichiro; Shintani, Yukako; Fukayama, Masashi; Nangaku, Masaomi. The reduced expression of proximal tubular transporters in acquired Fanconi syndrome with κ light chain deposition. Medical Molecular Morphology. 2016;49(1):48-52. PubMed - Comments: Used in: IHC |
| Uemura, Naoya; Murakami, Ryuta; Chiba, Yoichi; Yanase, Ken; Fujihara, Ryuji; Mashima, Masato; Matsumoto, Koichi; Kawauchi, Machi; Shirakami, Gotaro; Ueno, Masaki. Immunoreactivity of urate transporters, GLUT9 and URAT1, is located in epithelial cells of the choroid plexus of human brains. Neuroscience Letters. 2017;659:99-103. PubMed - Comments: Used in: IHC |